Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from genericsCNBC • 11/01/22
Pfizer Hits Trifecta, Boosting Guidance After Quarterly Beat And Unveiling A Potential WinInvestors Business Daily • 11/01/22
Pfizer says late-stage trial of RSV vaccine proved effective in reducing risk in very young childrenMarket Watch • 11/01/22
First RSV Vaccine On The Horizon—Pfizer Touts Strong Trial Results As Children's Hospitals Count Soaring CasesForbes • 11/01/22
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data showsCNBC • 11/01/22
Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine CandidateBusiness Wire • 11/01/22